Senti Biosciences

Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as gene circuits. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the intelligence of cell and gene therapies in order to enhance...

Synthetic biology,gene therapy,and cell therapy

Senti biosciences operates in the Biotechnology research industry.

Senti biosciences's revenue is 11m - 100m

Senti biosciences has 51 - 200 employees.